| Year |
Citation |
Score |
| 2023 |
Liao KL, Bai XF, Friedman A. IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer. Journal of Theoretical Biology. 111704. PMID 38104658 DOI: 10.1016/j.jtbi.2023.111704 |
0.322 |
|
| 2023 |
Zhu J, Yu J, Hu A, Liu JQ, Pan X, Xin G, Carson WE, Li Z, Yang Y, Bai XF. IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment. Journal of Immunology (Baltimore, Md. : 1950). PMID 37459051 DOI: 10.4049/jimmunol.2300176 |
0.485 |
|
| 2023 |
Lin CH, Talebian F, Yang L, Zhu J, Liu JQ, Zhao B, Basu S, Pan X, Chen X, Yan P, Carson WE, Xin G, Wen H, Wang R, Li Z, ... ... Bai XF, et al. CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells. Iscience. 26: 106904. PMID 37275530 DOI: 10.1016/j.isci.2023.106904 |
0.791 |
|
| 2023 |
Zhang X, Yu C, Liu JQ, Bai XF. Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodes. Frontiers in Immunology. 14: 1116749. PMID 36969215 DOI: 10.3389/fimmu.2023.1116749 |
0.435 |
|
| 2022 |
Bai XF, Chen Y, Zou MZ, Li CX, Zhang Y, Li MJ, Cheng SX, Zhang XZ. Homotypic Targeted Photosensitive Nanointerferer for Tumor Cell Cycle Arrest to Boost Tumor Photoimmunotherapy. Acs Nano. PMID 36341683 DOI: 10.1021/acsnano.2c06871 |
0.411 |
|
| 2022 |
Shi Y, Zhu J, Liu JQ, Talebian F, Li M, Bai XF. CD24 is expressed on FoxP3 regulatory T cells and regulates their function. American Journal of Translational Research. 14: 2291-2300. PMID 35559385 |
0.778 |
|
| 2022 |
Hu A, Zhu J, Zeng C, Lin CH, Yu J, Liu JQ, Lynch K, Talebian F, Pan X, Yan J, Dong Y, Li Z, Bai XF. IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. Journal of Immunology (Baltimore, Md. : 1950). 208: 2239-2245. PMID 35418466 DOI: 10.4049/jimmunol.2100885 |
0.79 |
|
| 2022 |
Liu JQ, Zhang C, Zhang X, Yan J, Zeng C, Talebian F, Lynch K, Zhao W, Hou X, Du S, Kang DD, Deng B, McComb DW, Bai XF, Dong Y. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 35301053 DOI: 10.1016/j.jconrel.2022.03.021 |
0.767 |
|
| 2021 |
Talebian F, Yu J, Lynch K, Liu JQ, Carson WE, Bai XF. CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 9: 739816. PMID 34692697 DOI: 10.3389/fcell.2021.739816 |
0.8 |
|
| 2021 |
Zou MZ, Li ZH, Bai XF, Liu CJ, Zhang XZ. Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy. Nano Letters. 21: 8609-8618. PMID 34661419 DOI: 10.1021/acs.nanolett.1c02482 |
0.341 |
|
| 2020 |
Liu JQ, Zhu J, Hu A, Zhang A, Yang C, Yu J, Ghoshal K, Basu S, Bai XF. Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? American Journal of Cancer Research. 10: 3565-3574. PMID 33294255 |
0.442 |
|
| 2020 |
Choueiry F, Torok M, Shakya R, Agrawal K, Deems A, Benner B, Hinton A, Shaffer J, Blaser BW, Noonan AM, Williams TM, Dillhoff M, Conwell DL, Hart PA, Cruz-Monserrate Z, ... Bai XF, et al. CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal For Immunotherapy of Cancer. 8. PMID 32581043 DOI: 10.1136/Jitc-2019-000189 |
0.524 |
|
| 2020 |
Xin C, Zhu J, Gu S, Yin M, Ma J, Pan C, Tang J, Zhang P, Liu Y, Bai XF, Mo X, Xu M, Zhu H. CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment. Cancer Immunology, Immunotherapy : Cii. PMID 32514618 DOI: 10.1007/S00262-020-02589-6 |
0.602 |
|
| 2020 |
Hu A, Ding M, Zhu J, Liu JQ, Pan X, Ghoshal K, Bai XF. Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy. Frontiers in Cell and Developmental Biology. 8: 210. PMID 32292786 DOI: 10.3389/fcell.2020.00210 |
0.512 |
|
| 2020 |
Liu JQ, Hu A, Zhu J, Yu J, Talebian F, Bai XF. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. Advances in Experimental Medicine and Biology. 1223: 155-165. PMID 32030689 DOI: 10.1007/978-3-030-35582-1_8 |
0.792 |
|
| 2019 |
Zou MZ, Liu WL, Gao F, Bai XF, Chen HS, Zeng X, Zhang XZ. Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re-Education. Advanced Materials (Deerfield Beach, Fla.). e1904495. PMID 31497903 DOI: 10.1002/Adma.201904495 |
0.348 |
|
| 2019 |
Deng RH, Zou MZ, Zheng D, Peng SY, Liu W, Bai XF, Chen HS, Sun Y, Zhou PH, Zhang XZ. Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal Therapy. Acs Nano. PMID 31246413 DOI: 10.1021/Acsnano.9B02993 |
0.345 |
|
| 2018 |
Zhu J, Liu JQ, Liu Z, Wu L, Shi M, Zhang J, Davis JP, Bai XF. Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11bGr-1 Myeloid Cells. Frontiers in Immunology. 9: 873. PMID 29740452 DOI: 10.3389/Fimmu.2018.00873 |
0.488 |
|
| 2018 |
Zhu J, Liu JQ, Shi M, Cheng X, Ding M, Zhang JC, Davis JP, Varikuti S, Satoskar AR, Lu L, Pan X, Zheng P, Liu Y, Bai XF. IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy. Jci Insight. 3. PMID 29618655 DOI: 10.1172/Jci.Insight.98745 |
0.568 |
|
| 2017 |
Zhu H, Gu S, Yin M, Shi M, Xin C, Zhu J, Wang J, Huang S, Xie C, Ma J, Pan C, Tang J, Xu M, Bai XF. Analysis of infantile fibrosarcoma reveals extensive T-cell responses within tumors: Implications for immunotherapy. Pediatric Blood & Cancer. PMID 28921877 DOI: 10.1002/Pbc.26813 |
0.469 |
|
| 2017 |
Liu Z, Wu L, Zhu J, Zhu X, Zhu J, Liu JQ, Zhang J, Davis JP, Varikuti S, Satoskar AR, Zhou J, Li MS, Bai XF. IL-27 signaling induces stem cell antigen-1 expression in T lymphocytes in vivo. Immunology. PMID 28758191 DOI: 10.1111/Imm.12805 |
0.551 |
|
| 2016 |
Liu JQ, Talebian F, Wu L, Liu Z, Li MS, Wu L, Zhu J, Markowitz J, Carson WE, Basu S, Bai XF. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 27385779 DOI: 10.4049/Jimmunol.1600052 |
0.802 |
|
| 2016 |
Zhao S, Zhang L, Han J, Chu J, Wang H, Chen X, Wang Y, Tun N, Lu L, Bai XF, Martha Y, Devine S, He X, Yu J. Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-Versus-Host Disease and Retains Graft-Versus-Leukemia Activity. Acs Nano. PMID 27224853 DOI: 10.1021/Acsnano.6B02206 |
0.411 |
|
| 2016 |
Zhu X, Liu Z, Liu JQ, Zhu J, Zhang J, Davis JP, Chu J, Yu J, Zhou J, Li MS, Bai XF. Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells. Journal of Leukocyte Biology. PMID 27106672 DOI: 10.1189/Jlb.3A1215-540R |
0.486 |
|
| 2015 |
Liu Z, Liu JQ, Shi Y, Zhu X, Liu Z, Li MS, Yu J, Wu LC, He Y, Zhang G, Bai XF. Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth. Oncoimmunology. 4: e989137. PMID 26140252 DOI: 10.4161/2162402X.2014.989137 |
0.549 |
|
| 2015 |
Wang L, Liu JQ, Talebian F, Liu Z, Yu L, Bai XF. IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology. 4: e1014232. PMID 26140236 DOI: 10.1080/2162402X.2015.1014232 |
0.829 |
|
| 2015 |
Li MS, Liu Z, Liu JQ, Zhu X, Liu Z, Bai XF. The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy. Immunotherapy. 7: 191-200. PMID 25713993 DOI: 10.2217/Imt.14.95 |
0.591 |
|
| 2014 |
Liao KL, Bai XF, Friedman A. Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesis. Plos One. 9: e110126. PMID 25356878 DOI: 10.1371/Journal.Pone.0110126 |
0.58 |
|
| 2014 |
Chu J, He S, Deng Y, Zhang J, Peng Y, Hughes T, Yi L, Kwon CH, Wang QE, Devine SM, He X, Bai XF, Hofmeister CC, Yu J. Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3989-4000. PMID 24677374 DOI: 10.1158/1078-0432.Ccr-13-2510 |
0.375 |
|
| 2014 |
Liao KL, Bai XF, Friedman A. Mathematical modeling of interleukin-27 induction of anti-tumor T cells response. Plos One. 9: e91844. PMID 24633175 DOI: 10.1371/Journal.Pone.0091844 |
0.65 |
|
| 2013 |
Liu Z, Yu J, Carson WE, Bai XF. The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response. American Journal of Translational Research. 5: 470-80. PMID 23977407 |
0.504 |
|
| 2013 |
Wang LX, Mei ZY, Zhou JH, Yao YS, Li YH, Xu YH, Li JX, Gao XN, Zhou MH, Jiang MM, Gao L, Ding Y, Lu XC, Shi JL, Luo XF, ... ... Bai XF, et al. Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses. Plos One. 8: e62924. PMID 23671644 DOI: 10.1371/Journal.Pone.0062924 |
0.614 |
|
| 2013 |
Liao KL, Bai XF, Friedman A. The role of CD200-CD200R in tumor immune evasion. Journal of Theoretical Biology. 328: 65-76. PMID 23541619 DOI: 10.1016/J.Jtbi.2013.03.017 |
0.635 |
|
| 2013 |
Wang Z, Liu JQ, Liu Z, Shen R, Zhang G, Xu J, Basu S, Feng Y, Bai XF. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. Journal of Immunology (Baltimore, Md. : 1950). 190: 2415-23. PMID 23345334 DOI: 10.4049/Jimmunol.1202535 |
0.6 |
|
| 2013 |
Liu Z, Liu JQ, Talebian F, Wu LC, Li S, Bai XF. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. European Journal of Immunology. 43: 468-79. PMID 23225163 DOI: 10.1002/Eji.201242930 |
0.793 |
|
| 2012 |
Talebian F, Bai XF. The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy. Oncoimmunology. 1: 971-973. PMID 23162775 DOI: 10.4161/Onci.20034 |
0.794 |
|
| 2012 |
Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl JW, Yu C, Shi FD, Whitacre CC, Trgovcich J, Bai XF. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 188: 3099-106. PMID 22387555 DOI: 10.4049/Jimmunol.1100106 |
0.77 |
|
| 2012 |
Talebian F, Liu JQ, Liu Z, Khattabi M, He Y, Ganju R, Bai XF. Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions. Plos One. 7: e31442. PMID 22319630 DOI: 10.1371/Journal.Pone.0031442 |
0.792 |
|
| 2012 |
Zhang X, Liu JQ, Shi Y, Reid HH, Boyd RL, Khattabi M, El-Omrani HY, Zheng P, Liu Y, Bai XF. CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes. European Journal of Immunology. 42: 924-35. PMID 22213356 DOI: 10.1002/Eji.201142024 |
0.517 |
|
| 2012 |
Wang LX, Talebian F, Liu JQ, Khattabi M, Yu L, Bai XF. IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. Scandinavian Journal of Immunology. 75: 273-81. PMID 22050574 DOI: 10.1111/J.1365-3083.2011.02662.X |
0.761 |
|
| 2011 |
Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846 |
0.301 |
|
| 2010 |
Wang L, Liu JQ, Talebian F, El-Omrani HY, Khattabi M, Yu L, Bai XF. Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. European Journal of Immunology. 40: 2569-79. PMID 20662098 DOI: 10.1002/Eji.201040472 |
0.808 |
|
| 2010 |
Liu JQ, Joshi PS, Wang C, El-Omrani HY, Xiao Y, Liu X, Hagan JP, Liu CG, Wu LC, Bai XF. Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs. Journal of Immunology (Baltimore, Md. : 1950). 184: 5435-43. PMID 20404277 DOI: 10.4049/jimmunol.0903322 |
0.359 |
|
| 2008 |
Carl JW, Bai XF. IL27: its roles in the induction and inhibition of inflammation. International Journal of Clinical and Experimental Pathology. 1: 117-23. PMID 18784808 |
0.324 |
|
| 2008 |
Carl JW, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF. Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. Journal of Immunology (Baltimore, Md. : 1950). 181: 320-8. PMID 18566397 |
0.46 |
|
| 2008 |
Liu R, Bai Y, Vollmer TL, Bai XF, Jee Y, Tang YY, Campagnolo DI, Collins M, Young DA, La Cava A, Shi FD. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Experimental Neurology. 211: 14-24. PMID 18353312 DOI: 10.1016/J.Expneurol.2007.11.004 |
0.491 |
|
| 2008 |
Liu JQ, Bai XF. Overcoming immune evasion in T cell therapy of cancer: lessons from animal models. Current Molecular Medicine. 8: 68-75. PMID 18289015 |
0.409 |
|
| 2008 |
Piao WH, Jee YH, Liu RL, Coons SW, Kala M, Collins M, Young DA, Campagnolo DI, Vollmer TL, Bai XF, La Cava A, Shi FD. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scandinavian Journal of Immunology. 67: 37-46. PMID 18052963 DOI: 10.1111/j.1365-3083.2007.02035.x |
0.493 |
|
| 2008 |
Bai X, Liu J. Identification of a novel tumor antigen that resembles mouse tumor rejection antigen P1A The Faseb Journal. 22: 521-521. DOI: 10.1096/fasebj.22.2_supplement.521 |
0.311 |
|
| 2007 |
Piao WH, Wong R, Bai XF, Huang J, Campagnolo DI, Dorr RT, Vollmer TL, Shi FD. Therapeutic effect of anthracene-based anticancer agent ethonafide in an animal model of multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 179: 7415-23. PMID 18025185 DOI: 10.4049/Jimmunol.179.11.7415 |
0.413 |
|
| 2007 |
Liu JQ, Carl JW, Joshi PS, RayChaudhury A, Pu XA, Shi FD, Bai XF. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 178: 6227-35. PMID 17475850 DOI: 10.4049/Jimmunol.178.10.6227 |
0.572 |
|
| 2006 |
Joshi PS, Liu JQ, Wang Y, Chang X, Richards J, Assarsson E, Shi FD, Ljunggren HG, Bai XF. Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms. Journal of Leukocyte Biology. 80: 1345-53. PMID 16997856 DOI: 10.1189/Jlb.0506305 |
0.436 |
|
| 2006 |
Bai XF, Liu JQ, Joshi PS, Wang L, Yin L, Labanowska J, Heerema N, Zheng P, Liu Y. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy. Cancer Research. 66: 8241-9. PMID 16912204 DOI: 10.1158/0008-5472.Can-06-0279 |
0.513 |
|
| 2006 |
Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis? International Immunology. 18: 537-44. PMID 16481342 DOI: 10.1093/Intimm/Dxh394 |
0.478 |
|
| 2005 |
Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. Journal of Immunology (Baltimore, Md. : 1950). 175: 7898-904. PMID 16339525 |
0.492 |
|
| 2005 |
Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, Wainstok R, Bai XF, Liu Y, Steinman RM. Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. The Journal of Experimental Medicine. 202: 1507-16. PMID 16330814 DOI: 10.1084/Jem.20050956 |
0.468 |
|
| 2005 |
May KF, Roychowdhury S, Bhatt D, Kocak E, Bai XF, Liu JQ, Ferketich AK, Martin EW, Caligiuri MA, Zheng P, Liu Y. Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood. 105: 1114-20. PMID 15486062 DOI: 10.1182/Blood-2004-07-2561 |
0.332 |
|
| 2004 |
Bai XF, Li O, Zhou Q, Zhang H, Joshi PS, Zheng X, Liu Y, Wang Y, Zheng P, Liu Y. CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 200: 447-58. PMID 15314074 DOI: 10.1084/Jem.20040131 |
0.517 |
|
| 2003 |
Sarma S, Bai XF, Liu JQ, May KF, Zheng P, Liu Y. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires. Cancer Research. 63: 6051-5. PMID 14522934 |
0.427 |
|
| 2003 |
Bai XF, Liu J, Li O, Zheng P, Liu Y. Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes. The Journal of Clinical Investigation. 111: 1487-96. PMID 12750398 DOI: 10.1172/Jci17656 |
0.447 |
|
| 2002 |
Gao JX, Zhang H, Bai XF, Wen J, Zheng X, Liu J, Zheng P, Liu Y. Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. The Journal of Experimental Medicine. 195: 959-71. PMID 11956287 DOI: 10.1084/Jem.20011948 |
0.429 |
|
| 2002 |
Bai XF, Liu J, May KF, Guo Y, Zheng P, Liu Y. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo. Blood. 99: 2880-9. PMID 11929778 DOI: 10.1182/Blood.V99.8.2880 |
0.537 |
|
| 2001 |
Liu X, Bai XF, Wen J, Gao JX, Liu J, Lu P, Wang Y, Zheng P, Liu Y. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. The Journal of Experimental Medicine. 194: 1339-48. PMID 11696598 DOI: 10.1084/Jem.194.9.1339 |
0.584 |
|
| 2001 |
Bai XF, Bender J, Liu J, Zhang H, Wang Y, Li O, Du P, Zheng P, Liu Y. Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens. Journal of Immunology (Baltimore, Md. : 1950). 167: 3936-43. PMID 11564812 DOI: 10.4049/Jimmunol.167.7.3936 |
0.531 |
|
| 2001 |
Bai XF, Gao JX, Liu J, Wen J, Zheng P, Liu Y. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Cancer Research. 61: 6860-7. PMID 11559562 |
0.411 |
|
| 2001 |
Guilloux Y, Bai XF, Liu X, Zheng P, Liu Y. Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells. Cancer Research. 61: 1107-12. PMID 11221840 |
0.342 |
|
| 2000 |
Bai XF, Liu JQ, Liu X, Guo Y, Cox K, Wen J, Zheng P, Liu Y. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 1227-32. PMID 10791997 DOI: 10.1172/Jci9012 |
0.443 |
|
| 1999 |
Sarma S, Guo Y, Guilloux Y, Lee C, Bai XF, Liu Y. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo. The Journal of Experimental Medicine. 189: 811-20. PMID 10049945 DOI: 10.1084/Jem.189.5.811 |
0.493 |
|
| 1999 |
Zhu J, Bai XF, Hedlund G, Björk J, Bakhiet M, Van Der Meide PH, Link H. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses. Clinical and Experimental Immunology. 115: 56-63. PMID 9933420 |
0.393 |
|
| 1998 |
Li H, Shi F, Bai X, Huang Y, Diab A, He B, Link H. Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis Journal of the Neurological Sciences. 161: 40-46. PMID 9879680 DOI: 10.1016/S0022-510X(98)00181-6 |
0.408 |
|
| 1998 |
Laytragoon-Lewin N, Duhony E, Bai XF, Mellstedt H. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells. European Journal of Haematology. 61: 266-71. PMID 9820634 DOI: 10.1111/J.1600-0609.1998.TB01713.X |
0.369 |
|
| 1998 |
Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. International Immunology. 10: 1139-48. PMID 9723700 DOI: 10.1093/Intimm/10.8.1139 |
0.387 |
|
| 1998 |
Xiao BG, Bai XF, Zhang GX, Link H. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. Journal of Neuroimmunology. 84: 230-7. PMID 9628468 DOI: 10.1016/S0165-5728(97)00264-6 |
0.473 |
|
| 1998 |
Li HL, Shi FD, Bai XF, Huang YM, van der Meide PH, Xiao BG, Link H. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma. Clinical Immunology and Immunopathology. 87: 15-22. PMID 9576006 DOI: 10.1006/Clin.1997.4495 |
0.304 |
|
| 1998 |
Shi FD, Bai XF, Xiao BG, van der Meide PH, Link H. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis. Journal of the Neurological Sciences. 155: 1-12. PMID 9562316 DOI: 10.1016/S0022-510X(97)00232-3 |
0.377 |
|
| 1997 |
Zhu J, Bai XF, Mix E, Link H. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. Journal of Neuroimmunology. 78: 108-16. PMID 9307234 |
0.338 |
|
| 1997 |
Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clinical Immunology and Immunopathology. 84: 85-94. PMID 9191887 |
0.327 |
|
| 1997 |
Bai XF, Shi FD, Zhu J, Xiao BG, Hedlund G, Link H. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions. Journal of Neuroimmunology. 76: 177-84. PMID 9184648 DOI: 10.1016/S0165-5728(97)00051-9 |
0.416 |
|
| 1997 |
Bai XF, Zhu J, Zhang GX, Kaponides G, Höjeberg B, van der Meide PH, Link H. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clinical Immunology and Immunopathology. 83: 117-26. PMID 9143372 |
0.419 |
|
| 1997 |
Zhu J, Bai X, Mix E, Meide PHvd, Zwingenberger K, Link H. Thalidomide Suppresses T- and B-cell Responses to Myelin Antigen in Experimental Allergic Neuritis Clinical Neuropharmacology. 20: 152-164. PMID 9099468 DOI: 10.1097/00002826-199704000-00007 |
0.42 |
|
| 1996 |
Xiao BG, Bao WJ, Bai XF, Link H. Induction of cytolysin mRNA in glial cells by IFN-gamma: a possible cytotoxic pathway in the CNS. Neuroreport. 8: 329-33. PMID 9051805 DOI: 10.1097/00001756-199612200-00065 |
0.311 |
|
| 1996 |
Xiao BG, Bai XF, Zhang GX, Höjeberg B, Link H. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. Neuroreport. 7: 1893-8. PMID 8905687 DOI: 10.1097/00001756-199608120-00004 |
0.391 |
|
| Show low-probability matches. |
